Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG40036)
| Regulator Name | Circ-PSEN1 (circRNA) | ||||
|---|---|---|---|---|---|
| Synonyms |
Circ-PSEN1
Click to Show/Hide
|
||||
| Gene Name | Circ-PSEN1 | ||||
| Regulator Type | circRNA | ||||
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
Circ-PSEN1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Transferrin receptor protein 1 (TFRC) [Driver; Suppressor; Marker]
| In total 1 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
| Target for Ferroptosis | Marker/Suppressor/Driver | |||
| Responsed Disease | Retinopathy | ICD-11: 9B71 | ||
| Pathway Response | Glutathione metabolism | hsa00480 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
In Vitro Model |
ARPE-19 cells | Normal | Homo sapiens | CVCL_0145 |
| Response regulation | Downregulation of circ-PSEN1 ameliorates HG-induced ferroptosis in ARPE19 cells via miR-200b-3p/CFL2 and may be a novel therapeutic target for diabetic retinopathy. Enhancement of CFL2 suppressed the mRNA and protein expression of GPX4 and SLC7A11. However, TFR1 expression was promoted. | |||
Phospholipid hydroperoxide glutathione peroxidase (GPX4) [Suppressor]
| In total 1 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
| Target for Ferroptosis | Suppressor | |||
| Responsed Disease | Retinopathy | ICD-11: 9B71 | ||
| Pathway Response | Glutathione metabolism | hsa00480 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
In Vitro Model |
ARPE-19 cells | Normal | Homo sapiens | CVCL_0145 |
| Response regulation | Downregulation of circ-PSEN1 ameliorates HG-induced ferroptosis in ARPE19 cells via miR-200b-3p/CFL2 and may be a novel therapeutic target for diabetic retinopathy. Enhancement of CFL2 suppressed the mRNA and protein expression of GPX4 and SLC7A11. However, TFR1 expression was promoted. | |||
Retinopathy [ICD-11: 9B71]
| In total 2 item(s) under this disease | ||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
| Target Regulator | Circ-PSEN1 (circRNA) | circRNA | ||
| Pathway Response | Glutathione metabolism | hsa00480 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
In Vitro Model |
ARPE-19 cells | Normal | Homo sapiens | CVCL_0145 |
| Response regulation | Downregulation of circ-PSEN1 ameliorates HG-induced ferroptosis in ARPE19 cells via miR-200b-3p/CFL2 and may be a novel therapeutic target for diabetic retinopathy. Enhancement of CFL2 suppressed the mRNA and protein expression of GPX4 and SLC7A11. However, TFR1 expression was promoted. | |||
| Experiment 2 Reporting the Ferroptosis-centered Disease Response | [1] | |||
| Target Regulator | Circ-PSEN1 (circRNA) | circRNA | ||
| Pathway Response | Glutathione metabolism | hsa00480 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
In Vitro Model |
ARPE-19 cells | Normal | Homo sapiens | CVCL_0145 |
| Response regulation | Downregulation of circ-PSEN1 ameliorates HG-induced ferroptosis in ARPE19 cells via miR-200b-3p/CFL2 and may be a novel therapeutic target for diabetic retinopathy. Enhancement of CFL2 suppressed the mRNA and protein expression of GPX4 and SLC7A11. However, TFR1 expression was promoted. | |||
